Skip to main content

Table 5 Multivariate Cox regression for cases with invasive carcinomas

From: Immunohistochemical evaluation of ROCK activation in invasive breast cancer

 

Hazard ratio (95 % CI)

P

Model 1

Age (year)

1.019 (1.001, 1.037)

0.044

Grade

 1

1

 

 2

1.935 (0.258, 14.529)

0.521

 3

1.062 (0.132, 8.565)

0.955

Stage

 I

1

 

 II

1.811 (0.673, 4.875)

0.240

 III

6.144 (2.264, 16.677)

< 0.001

 IV

58.450 (9.985, 342.165)

< 0.001

ER+

0.403 (0.169, 0.963)

0.041

PR+

1.768 (0.734, 4.262)

0.204

HER2+

1.302 (0.688, 2.463)

0.418

Nuclear pROCKII ≥ 30 %

1.414 (0.715, 2.794)

0.319

Model 2

Age (year)

1.019 (1.000, 1.039)

0.050

Grade

 1

1

 

 2

3.244 (0.442, 23.801)

0.247

 3

2.299 (0.297, 17.784)

0.425

ER+

0.563 (0.241, 1.316)

0.185

PR+

1.253 (0.532, 2.952)

0.605

HER2+

1.315 (0.713, 2.425)

0.381

Nuclear pROCKII ≥ 30 %

2.116 (1.152, 3.888)

0.016

  1. Bold values indicate statistical significance (P < 0.05). ER, estrogen receptor; PR, progesterone receptor